The US drug wholesaling industry is stable post-opioid settlement, with focus shifting to fund management and pharmacy benefit managers. The Big Three wholesalers are financially strong, expanding ...
A conversation with Kenco’s Tim McClatchy explores how pharmaceutical logistics providers are strengthening cybersecurity ...
In today’s Pharma Pulse, Eli Lilly’s orforglipron shows superior blood sugar control over oral semaglutide, while GSK secures ...
Medicare negotiation applies first to Part D retail drugs and later to Part B physician-administered agents, with negotiated maximum fair prices phased in beginning January 1, 2026. The $2,100 annual ...
Valerie Bandy and Ryan Rotar, both from Tecsys, examine how hospital pharmacy leaders are reshaping their expectations and prioritizing value-driven partnerships over traditional transactional vendor ...
In today’s Pharma Pulse, the FDA unveils a Plausible Mechanism framework to fast-track ultra-rare disease therapies, while ...
A conservative 3% trend means a $100 billion Medicare Advantage book could face a $3 billion shortfall. Even before the Final ...
In the first part of his Pharma Commerce video interview, John Stanford, Incubate’s executive director, explains how third ...
In today’s Pharma Pulse, Johnson & Johnson commits over $1 billion to a new biomanufacturing site in Pennsylvania, while Hims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results